Onward Medical Statistics
Total Valuation
Onward Medical has a market cap or net worth of 233.54 million. The enterprise value is 182.53 million.
| Market Cap | 233.54M |
| Enterprise Value | 182.53M |
Important Dates
The next estimated earnings date is Tuesday, June 17, 2025.
| Earnings Date | Jun 17, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 44.65M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +47.86% |
| Shares Change (QoQ) | +57.77% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 26.28M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 129.71 |
| PB Ratio | 4.69 |
| P/TBV Ratio | 5.99 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -4.93 |
| EV / Sales | 92.50 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -5.52 |
Financial Position
The company has a current ratio of 6.85, with a Debt / Equity ratio of 0.31.
| Current Ratio | 6.85 |
| Quick Ratio | 6.57 |
| Debt / Equity | 0.31 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.47 |
| Interest Coverage | -17.61 |
Financial Efficiency
Return on equity (ROE) is -108.28% and return on invested capital (ROIC) is -44.47%.
| Return on Equity (ROE) | -108.28% |
| Return on Assets (ROA) | -36.37% |
| Return on Invested Capital (ROIC) | -44.47% |
| Return on Capital Employed (ROCE) | -52.13% |
| Revenue Per Employee | 17,480 |
| Profits Per Employee | -359,090 |
| Employee Count | 103 |
| Asset Turnover | 0.03 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -22.04% in the last 52 weeks. The beta is 0.86, so Onward Medical's price volatility has been lower than the market average.
| Beta (5Y) | 0.86 |
| 52-Week Price Change | -22.04% |
| 50-Day Moving Average | 5.44 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 43.15 |
| Average Volume (20 Days) | 1,335 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Onward Medical had revenue of 1.80 million and -36.99 million in losses. Loss per share was -0.83.
| Revenue | 1.80M |
| Gross Profit | -12.60M |
| Operating Income | -36.07M |
| Pretax Income | -37.03M |
| Net Income | -36.99M |
| EBITDA | -35.72M |
| EBIT | -36.07M |
| Loss Per Share | -0.83 |
Balance Sheet
The company has 62.16 million in cash and 15.62 million in debt, giving a net cash position of 46.54 million.
| Cash & Cash Equivalents | 62.16M |
| Total Debt | 15.62M |
| Net Cash | 46.54M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 49.75M |
| Book Value Per Share | 1.11 |
| Working Capital | 56.25M |
Cash Flow
In the last 12 months, operating cash flow was -32.88 million and capital expenditures -155,296, giving a free cash flow of -33.04 million.
| Operating Cash Flow | -32.88M |
| Capital Expenditures | -155,296 |
| Free Cash Flow | -33.04M |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | -2,003.68% |
| Pretax Margin | -2,056.64% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Onward Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -47.86% |
| Shareholder Yield | n/a |
| Earnings Yield | -15.84% |
| FCF Yield | -14.15% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Onward Medical has an Altman Z-Score of -0.31. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.31 |
| Piotroski F-Score | n/a |